IC50: 22.6 nM, 9.37 nM, 0.3724 muM, and 0.1810 muM for AChE, BCHE, MAO-A and MAO-B, respectively
Type : Multitarget,Monoamine-oxidase-inhibitor,Acridine,Derivative of Tacrine,Alkyl linked bis-ligand
Chemical_Nomenclature : (R)-N-(9-(4-(2-(methyl(prop-2-ynyl)amino)propyl)phenoxy)nonyl)-1,2,3,4-tetrahydroacridin-9-amine
Canonical SMILES : C1=CC=C2C(=C1)C(=C3C(=N2)CCCC3)NCCCCCCCCCOCC4=CC=C(C=C4)CC(N(C)CC#C)C
InChI : InChI=1S\/C36H49N3O\/c1-4-25-39(3)29(2)27-30-20-22-31(23-21-30)28-40-26-15-9-7-5-6-8-14-24-37-36-32-16-10-12-18-34(32)38-35-19-13-11-17-33(35)36\/h1,10,12,16,18,20-23,29H,5-9,11,13-15,17,19,24-28H2,2-3H3,(H,37,38)
InChIKey : IHKYXYWTTDJQOB-UHFFFAOYSA-N
Other name(s) : Compound 8g
MW : 539.80
Formula : C36H49N3O
CAS_number :
PubChem :
UniChem : IHKYXYWTTDJQOB-UHFFFAOYSA-N
IUPHAR :
Wikipedia :
Families : Tacrine-selegiline-8g ligand of proteins in family: BCHE || ACHE
Stucture :
Protein : human-BCHE || human-ACHE
Title : A novel series of tacrine-selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer's disease - Lu_2013_Eur.J.Med.Chem_62C_745 |
Author(s) : Lu C , Zhou Q , Yan J , Du Z , Huang L , Li X |
Ref : Eur Journal of Medicinal Chemistry , 62C :745 , 2013 |
Abstract : Lu_2013_Eur.J.Med.Chem_62C_745 |
ESTHER : Lu_2013_Eur.J.Med.Chem_62C_745 |
PubMedSearch : Lu_2013_Eur.J.Med.Chem_62C_745 |
PubMedID: 23454517 |